Capricor Therapeutics, Inc. is a pioneering biotechnology company headquartered in Beverly Hills, California, dedicated to the advancement of cell- and exosome-based therapies targeting a range of serious diseases. The firm’s innovative approach to regenerative medicine leverages proprietary technologies to develop solutions that address significant unmet medical needs within various therapeutic areas. With a robust R&D pipeline and a strong commitment to scientific excellence, Capricor is well-positioned to enhance patient outcomes and establish strategic partnerships in the biopharmaceutical landscape, aiming to drive transformative advancements in healthcare. Show more

Location: 10865 ROAD TO THE CURE, SAN DIEGO, CA, UNITED STATES, 92121, San Diego, CA, 92121, USA | Website: https://www.capricor.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

1.253B

52 Wk Range

$4.30 - $40.37

Previous Close

$23.03

Open

$23.36

Volume

1,131,185

Day Range

$23.23 - $25.21

Enterprise Value

1.249B

Cash

19.51M

Avg Qtr Burn

-19.69M

Insider Ownership

16.80%

Institutional Own.

39.19%

Qtr Updated

09/30/25